Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Loxam Teri, Director. Director active across 2 companies, notably Vaxcyte, Inc.. In total, 11 filings have been recorded. Activity tracked since 1 June 2022. The latest transaction was disclosed on 26 March 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Teri Loxam is a Board Member at Vaxcyte, Inc. She participates in the governance of the company, contributing to strategic decision-making and the overall direction of the organization. Her experience in the biopharmaceutical sector is an asset for Vaxcyte in achieving its objectives.